CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) — FDA Approval ANDA077654 (GLENMARK PHARMS LTD)
CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) — FDA Approval ANDA077654 (GLENMARK PHARMS LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CITALOPRAM HYDROBROMIDE; Active ingredients: CITALOPRAM HYDROBROMIDE; Application number: ANDA077654.
| Brand name | CITALOPRAM HYDROBROMIDE |
|---|---|
| Active ingredients | CITALOPRAM HYDROBROMIDE |
| Application number | ANDA077654 |
| Sponsor | GLENMARK PHARMS LTD |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 3 |
| First approval date | 20090227 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →